Nkarta (NKTX) Current Leases (2019 - 2026)
Nkarta's (NKTX) quarterly Current Leases came in at $7.1 million in Q1 2026, up 19.01% year-on-year from $6.0 million in Q1 2025, and up 2.79% quarter-over-quarter from $6.9 million in Q4 2025.
Nkarta (NKTX) Current Leases (2019 - 2026) Analysis & Trends
Nkarta's Current Leases history runs 8 years deep, the most recent figure standing at $7.1 million for Q1 2026.
- On a quarterly basis, Current Leases rose 19.01% year-over-year to $7.1 million in Q1 2026; TTM through Mar 2026 was $7.1 million, a 19.01% increase from a year earlier, with the FY2025 full-year figure at $6.9 million, up 13.87% from the prior year.
- Current Leases advanced to $7.1 million in Q1 2026 per NKTX's latest filing, from $6.9 million in the prior quarter.
- Across five years, Current Leases topped out at $7.1 million in Q1 2026 and bottomed at $2.5 million in Q1 2022.
- The 5-year median for Current Leases is $6.0 million (2023), against an average of $5.7 million.
- Across the five-year window, Current Leases surged 129.62% in 2023 and decreased 8.56% in 2024, its largest moves.
- Year by year, Current Leases stood at $4.2 million in 2022, then soared by 42.83% to $6.1 million in 2023, then fell by 0.31% to $6.0 million in 2024, then grew by 13.87% to $6.9 million in 2025, then rose by 2.79% to $7.1 million in 2026.
- Per Business Quant, the three latest NKTX Current Leases figures stand at $7.1 million (Q1 2026), $6.9 million (Q4 2025), and $6.4 million (Q3 2025).
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Current Leases (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - | 531,233.95 |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - | - |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn | 20.58 Mn |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - | 872,589.03 |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn | - |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn | 720.00 Mn |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn | 11.00 Mn |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - | 16.61 Mn |
| 10 | Nkarta | 170.79 Mn | 170.79 Mn | - | 7.08 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 7.08 Mn |
| Dec 31, 2025 | 6.89 Mn |
| Sep 30, 2025 | 6.37 Mn |
| Jun 30, 2025 | 6.91 Mn |
| Mar 31, 2025 | 5.95 Mn |
| Dec 31, 2024 | 6.05 Mn |
| Sep 30, 2024 | 6.76 Mn |
| Jun 30, 2024 | 5.53 Mn |
| Mar 31, 2024 | 6.08 Mn |
| Dec 31, 2023 | 6.07 Mn |
| Sep 30, 2023 | 6.06 Mn |
| Jun 30, 2023 | 6.05 Mn |
| Mar 31, 2023 | 5.75 Mn |
| Dec 31, 2022 | 4.25 Mn |
| Sep 30, 2022 | 5.36 Mn |
| Jun 30, 2022 | 3.07 Mn |
| Mar 31, 2022 | 2.51 Mn |
| Dec 31, 2021 | 2.48 Mn |
| Sep 30, 2021 | 2.46 Mn |
| Jun 30, 2021 | 2.29 Mn |